Quantcast

Latest Gastrointestinal cancer Stories

2014-10-01 12:30:37

Annual run/walk adding third Challenge in Newark to raise money to fight colorectal cancer WHITE PLAINS, N.Y., Oct. 1, 2014 /PRNewswire/ -- The Colon Cancer Challenge Foundation (CCCF), a New York-based nonprofit dedicated to reducing colorectal cancer incidence and death throughout the United States, has added a third Colon Cancer Challenge run/walk on November 15 at the Prudential Center in Newark, New Jersey, as it moves into the second decade of its annual public awareness and...

2014-09-24 16:25:48

Bipartisan committee forms to provide expertise, advice and guidance in establishing legislative priorities for Fight Colorectal Cancer. ALEXANDRIA, Va., Sept. 24, 2014 /PRNewswire-iReach/ -- Today Fight Colorectal Cancer announced the establishment of the Fight Colorectal Cancer Congressional Advisory Committee. Reps. Donald M. Payne, Jr. (D-NJ), Charlie Dent (R-PA), Mike Fitzpatrick (R-PA) and Leonard Lance (R-NJ) will serve as inaugural members and advise Fight Colorectal Cancer...

2014-09-23 08:31:21

DAVIE, Fla., Sept. 23, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) has partnered with Inspire to launch a peer-to-peer Support Community to connect stomach cancer patients, families, friends and caregivers. The support community provides support and inspiration for those who have been diagnosed with stomach cancer and is a safe and secure place for patients and caregivers to support and connect with one another. More than 100 national patient advocacy...

2014-09-18 08:26:01

-- Phase III RAINBOW Trial Data Published in The Lancet Oncology -- INDIANAPOLIS, Sept. 18, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that results of the global Phase III trial of ramucirumab (CYRAMZA(TM)) in combination with paclitaxel in patients with advanced gastric (stomach) cancer or gastroesophageal junction (GEJ) adenocarcinoma were published in the online version of The Lancet Oncology. In the trial, known as RAINBOW, the addition of ramucirumab to...

2014-08-28 08:28:19

Run with the DDF Dream Team in Chicago on September 7 CHICAGO, Aug. 28, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is excited to have a team in this year's Chicago Half Marathon on Sunday, September 7, 2014, beginning at 7 a.m. in Jackson Park. The "Dream Team" runners receive a DDF race shirt which helps the organization raise awareness about gastric cancer. Runners also raise funds from friends and family to support their extraordinary efforts of...

botox for gastric cancer
2014-08-23 05:56:29

Eric Hopton for redOrbit.com - Your Universe Online Botox is in the news again, and this time it looks like potentially good news for some cancer treatments. Although it still receives mixed reviews as a result of its association with cosmetic procedures and some high-profile failures, the medical world is discovering new ways in which Botox can help treat a wide range of conditions. In a new process which has been described as “cheap, safe and efficient,” researchers have found...

2014-08-20 08:28:24

Nicole Reichenbach climbs in honor of her father who moved mountains for her family and lost his life to stomach cancer NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Nicole Reichenbach, New York Chapter President of Debbie's Dream Foundation: Curing Stomach Cancer (DDF), will climb Mount Kilimanjaro on Thursday, August 21, 2014, in honor of her father who passed away from gastric cancer. She is fundraising for Debbie's Dream Foundation that is a nonprofit organization that raises...

2014-08-13 23:01:47

North Texas Chapter of the Association of Clinical Research Professionals and Baylor Research Institute, join with Myriad Genetics, Lynch Syndrome International, Progeny and Ambry Genetics to bring global expert, Patrick Lynch, JD, MD, to Dallas to present lifesaving information on Lynch syndrome (HNPCC), a hereditary cancer condition, to bring a community outreach presentation, Saturday, August 16, 2014. Dallas, TX (PRWEB) August 13, 2014 The North Texas Chapter of the Association of...

2014-08-12 08:29:37

First time in history a technology receives FDA approval and proposed national coverage by CMS on the same day MADISON, Wis., Aug. 12, 2014 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company's noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been...

2014-08-08 10:45:03

Queen Mary, University of London New research from Queen Mary University of London (QMUL) reveals taking aspirin can significantly reduce the risk of developing – and dying from – the major cancers of the digestive tract, i.e. bowel, stomach and oesophageal cancer. For the first time, scientists have reviewed all the available evidence from many studies and clinical trials assessing both the benefits and harms of preventive use of aspirin. Conclusions of the study, funded by Cancer...


Latest Gastrointestinal cancer Reference Libraries

Gastroscopy
2013-03-04 10:13:56

The esophagogastroduodenoscopy is a medical diagnostic procedure used in internal medicine to view the upper part of the gastrointestinal tract. This non-invasive procedure is used for many complaints and requires little to no time for recovery from the procedure. Reasons for the Procedure Patients present to their physician with physical complaints. For example, a patient may come into the office and say they have been feeling tired and forgetful. Through many tests and evaluations,...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related